Cerro Pacific Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cerro Pacific Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$280K	Sell	4,037 -46	-1%	-$3.24K	0.15%	120
2022 Q4	$294K	Sell	4,083 -19	-0.5%	-$1.43K	0.16%	134
2022 Q3	$292K	Buy	4,102 +186	+5%	+$13.5K	0.18%	121
2022 Q2	$302K	Buy	3,916 +119	+3%	+$9.06K	0.19%	122
2022 Q1	$277K	Buy	3,797 +9	+0.2%	+$604	0.17%	112
2021 Q4	$236K	Hold	3,788	–	–	0.15%	112
2021 Q3	$224K	Sell	3,788 -76	-2%	-$5K	0.16%	116
2021 Q2	$258K	Buy	+3,864	New	+$252K	0.19%	106
2020 Q4	$239K	Buy	+3,846	New	+$236K	0.14%	101

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cerro Pacific Wealth Advisors's BMY Position: Q1 2023 in Review

Cerro Pacific Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2023, selling an estimated $3.24K and leaving 4,037 shares worth $280K. The position accounts for 0.15% of the portfolio, ranked #120.

Cerro Pacific Wealth Advisors first reported a position in BMY in Q4 2020 and has held it in 9 quarters since. The position peaked at $302K in Q2 2022. 2,542 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Cerro Pacific Wealth Advisors held 4,037 shares of Bristol-Myers Squibb worth $280K as of Q1 2023.
Cerro Pacific Wealth Advisors sold 46 Bristol-Myers Squibb shares in Q1 2023, an estimated $3.24K.
Bristol-Myers Squibb made up 0.15% of Cerro Pacific Wealth Advisors's portfolio in Q1 2023, its #120 holding.
Cerro Pacific Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 9 quarters since.
Cerro Pacific Wealth Advisors's Bristol-Myers Squibb position peaked at $302K in Q2 2022.
2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q1 2023, filed 10 May 2023.